About Igma Limited
Data last updated:
Igma Limited is a public limited company based in Raipur, Chhattisgarh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 28 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chhattisgarh, under CIN U24304CT2019PLC009496. Its GSTIN is 22AAFCI3883F1ZO (Chhattisgarh).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹65 Lakh. It is led by directors including Aryan Khatri and Manohar Khatri.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 207 – 211 Aushadhi Vatika Medical Complex Dumartarai, Raipur, Chhattisgarh, India – 492015.
As per the financials filed for FY 2022, the company reported a revenue of ₹5.68 Lakh, a decline of 98% compared to the previous year. For the same year it recorded a net loss of ₹6.8 Lakh (net margin -119.7%) and EBITDA of -₹5.72 Lakh (EBITDA margin -100.7%).
As per MCA filings, the company has open charges of ₹6.88 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 2 cases are pending.
For more details, the company can be reached via its website igmalimited.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address207 – 211 Aushadhi Vatika Medical Complex Dumartarai, Raipur, Chhattisgarh, India – 492015
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Igma Limited
The main business activities of Igma are trade and manufacturing. In detail, this covers wholesale trading and chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products. 2 activity segments are registered with the MCA.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Igma Limited FY 2023 filings available
Igma Limited reported revenue of ₹5.68 Lakh (down 98% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR) of Igma Limited
Revenue fell 98% in the latest year. EBITDA fell 302% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Igma Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | -₹5.72 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | -₹6.8 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Igma Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -100.7% | •••• | •••• |
| Net Profit Margin | -119.7% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Igma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Igma Limited
Igma Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alchemist Chemsynth Pharma Private Limited | ₹5.76 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | New Delhi, Delhi, India |
| Mancure Medisynthesis Private Limited | ₹5.76 Lakh (FY 2025) | •••• | •••• | 54.0% | •••• | Noida, Uttar Pradesh, India |
| Zebra Medicare India Private Limited | ₹5.74 Lakh (FY 2025) | •••• | •••• | 57.0% | •••• | Baddi, Himachal Pradesh, India |
| Dent Smith Med India Private Limited | ₹5.73 Lakh (FY 2020) | •••• | •••• | 799.0% | •••• | Chennai, Tamil Nadu, India |
| SPR Lifesciences Private Limited | ₹5.69 Lakh (FY 2021) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Igma Limited this company | ₹5.68 Lakh (FY 2022) | •••• | •••• | -98.0% | •••• | Raipur, Chhattisgarh, India |
| Invent Bio-Tech Private Limited | ₹5.66 Lakh (FY 2025) | •••• | •••• | -9.0% | •••• | Mau, Uttar Pradesh, India |
| Advision Industries Private Limited | ₹5.62 Lakh (FY 2022) | •••• | •••• | 370.0% | •••• | Lucknow, Uttar Pradesh, India |
| MV Pharmacuticals Marketing Private Limited | ₹5.62 Lakh (FY 2021) | •••• | •••• | -18.0% | •••• | Pune, Maharashtra, India |
| Shrikar Pharmaceuticals Private Limited | ₹5.61 Lakh (FY 2025) | •••• | •••• | 0.0% | •••• | Uttar Pradesh, India |
| Horizon Lifesciences Private Limited | ₹5.59 Lakh (FY 2018) | •••• | •••• | 14.0% | •••• | Boriya, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Igma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Igma Limited
Igma Limited is audited by RIJWANI & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RIJWANI & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Igma Limited
Igma has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aryan Khatri | Director | 28 Aug 2019 | 7 Years 1 Months | Current |
| Manohar Khatri | Director | 28 Aug 2019 | 7 Years 1 Months | Current |
| Avinash Khatri | Director | 28 Aug 2019 | 7 Years 1 Months | Current |
Ownership and Shareholding of Igma Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Igma Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Oct 2025 | Hdfc Bank Limited | ₹6 Lakh | Open |
| 20 Aug 2025 | Others | ₹6.45 Cr | Open |
| 31 Mar 2025 | Hdfc Bank Limited | ₹36.71 Lakh | Open |
Total charge records: 3 View all charges
Legal Cases of Igma Limited
Igma Limited has 2 court cases on record: 2 filed against it. All cases are pending. Status as checked between 21 Sep 2026 and 30 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 2 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Court case (CS (COMM.)) | Filed against the company by Wings Pharmaceuticals Pvt Ltd | Pending |
| District court, Ahmedabad, Gujarat | Court case (TMSUIT) | Filed against the company by Smartway Wellness Private Limited | Pending |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Igma Limited
Employment history and EPFO contributions of people linked to Igma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Igma Limited
Igma Limited has 3 board changes on record since 2019: 3 appointments. The latest: Aryan Khatri was appointed as Director on 28 Aug 2019.
Credit Ratings, Litigation & Regulatory Alerts for Igma Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Igma Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Igma Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Igma Limited
Igma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 22AAFCI3883F1ZO | Chhattisgarh | Active | 28 Nov 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Igma Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Igma Limited
Igma is an active public limited company based in Raipur, Chhattisgarh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 28 August 2019 (7+ years old) and is registered under CIN U24304CT2019PLC009496.
Igma reported revenue of ₹5.68 Lakh for FY 2022 (down 98% YoY).
Igma has 3 current directors:
- Aryan Khatri - Director
- Manohar Khatri - Director
- Avinash Khatri - Director
Igma reported a net loss of ₹6.8 Lakh (net margin -119.7%) and EBITDA of -₹5.72 Lakh (EBITDA margin -100.7%) for FY 2022, as per its filed financial statements.
The GSTIN of Igma is 22AAFCI3883F1ZO, registered in Chhattisgarh.
The CIN (Corporate Identification Number) of Igma is U24304CT2019PLC009496. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Igma has 2 court cases on record: 2 filed against it. 2 are pending.
Igma was incorporated on 28 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chhattisgarh.
The peers of Igma by revenue are Alchemist Chemsynth Pharma Private Limited, Mancure Medisynthesis Private Limited, Zebra Medicare India Private Limited, Dent Smith Med India Private Limited, SPR Lifesciences Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Aryan Khatri was appointed as Director on 28 Aug 2019. Avinash Khatri was appointed as Director on 28 Aug 2019. Manohar Khatri was appointed as Director on 28 Aug 2019.
Igma can be reached through the website igmalimited.com. Its registered office is in Raipur, Chhattisgarh, India.